Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer
Clinical trial NCT00612586 · COMPLETED
Trial details
- NCT number
- NCT00612586
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-01-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.